1 – 10 of 10
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
(
- Contribution to journal › Article
- 2009
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
(
- Contribution to journal › Article
- 2008
-
Mark
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
(
- Contribution to journal › Article
-
Mark
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
(
- Contribution to journal › Article
-
Mark
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
(
- Contribution to journal › Scientific review
- 2007
-
Mark
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer
(
- Contribution to journal › Article
- 2006
-
Mark
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
(
- Contribution to journal › Article